Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD235a Mouse anti-Human, FITC, Clone: CLB-ery-1 (AME-1), Invitrogen™ Non-distribution product as customer accommodation.

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MHGLA01

 View more versions of this product

Catalog No. 50-112-1238


Add to cart

Description

Description

R-phycoerythrin (PE) is a stable and highly soluble phycobiliprotein which provides maximal absorbance and fluorescence without susceptibility to internal or external fluorescence quenching, thus providing an exceptional quantum yields and molar extinction coefficients. This antibody recognizes a papain-sensitive epitope in the extracellular domain of the sialoglycoprotein known as glycophorin A (CD235a).

Glycophorin A is a sialoglycoprotein present on red blood cells (RBC) and erythroid precursor cells. It has been shown that glycophorins acts as the receptor for Sandei virus and parvovirus.
Specifications

Specifications

CD235a
Monoclonal
FITC
GYPA
Liquid
GYPA
Human Glycophorin A (CD235a)
Purified
ASR
Antibody
Monoclonal
Human
Flow Cytometry
CLB-ery-1 (AME-1)
PBS with BSA and 0.1% sodium azide
P02724
GYPA, glycophorin A, HGNC:4702, GPA, GPErik, GPSAT, HGpMiV, HGpMiX, HGpMiXI, HGpStaC, MN, MNS , Mi.V glycoprotein
Mouse
IgG1
0.5 mL
4° C, store in dark
Primary
2993
Documents
Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit